• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of Clinical and Pathological Staging in Patients with Head and Neck Cancer After Neck Dissection.颈部解剖术后头颈癌患者临床分期与病理分期的比较。
Int Arch Otorhinolaryngol. 2023 Sep 14;27(4):e571-e578. doi: 10.1055/s-0042-1758208. eCollection 2023 Oct.
2
Comparison Between Clinical and Pathological Staging After Elective Neck Dissection in Head and Neck Cancer.头颈癌选择性颈清扫术后临床分期与病理分期的比较
Cureus. 2023 Jun 24;15(6):e40881. doi: 10.7759/cureus.40881. eCollection 2023 Jun.
3
Correlation of Clinical and Pathological TNM Staging With Histopathological Grading in Oral Squamous Cell Carcinoma.口腔鳞状细胞癌临床及病理TNM分期与组织病理学分级的相关性
Cureus. 2024 May 23;16(5):e60912. doi: 10.7759/cureus.60912. eCollection 2024 May.
4
Occult Nodal Disease and Occult Extranodal Extension in Patients With Oropharyngeal Squamous Cell Carcinoma Undergoing Primary Transoral Robotic Surgery With Neck Dissection.接受初次经口机器人手术联合颈部清扫术的口咽鳞状细胞癌患者的隐匿性淋巴结疾病和隐匿性结外扩展
JAMA Otolaryngol Head Neck Surg. 2019 Aug 1;145(8):701-707. doi: 10.1001/jamaoto.2019.1186.
5
Comparison of clinical and pathological staging in head and neck squamous cell carcinoma: results from Intergroup Study ECOG 4393/RTOG 9614.头颈部鳞状细胞癌临床分期与病理分期的比较:ECOG 4393/RTOG 9614组间研究结果
Arch Otolaryngol Head Neck Surg. 2009 Sep;135(9):851-8. doi: 10.1001/archoto.2009.123.
6
Nodal Yield in Level II-IV Neck Dissections in Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌II-IV级颈部清扫术中的淋巴结产出量
Cureus. 2024 Jun 27;16(6):e63310. doi: 10.7759/cureus.63310. eCollection 2024 Jun.
7
Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.头颈部癌症患者治疗起始时间延长与病理性升级相关:增加死亡率的机制。
Cancer. 2018 Apr 1;124(7):1400-1414. doi: 10.1002/cncr.31213. Epub 2018 Jan 9.
8
The Indications for Elective Neck Dissection in T1N0M0 Oral Cavity Squamous Cell Carcinoma.T1N0M0 口腔鳞状细胞癌选择性颈清扫术的适应证。
J Oral Maxillofac Surg. 2021 Aug;79(8):1779-1793. doi: 10.1016/j.joms.2021.01.042. Epub 2021 Feb 24.
9
Patterns of cervical lymph node metastasis in supraglottic laryngeal cancer and therapeutic implications of surgical staging of the neck.声门上型喉癌颈淋巴结转移模式及颈淋巴结外科分期的治疗意义。
Eur Arch Otorhinolaryngol. 2021 Dec;278(12):5021-5027. doi: 10.1007/s00405-021-06753-1. Epub 2021 Mar 27.
10
Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.手术治疗 p16+口咽癌的独特预后因素和生存情况。
Laryngoscope. 2012 Sep;122 Suppl 2:S13-33. doi: 10.1002/lary.23493.

本文引用的文献

1
Time between Diagnosis and Treatment of Hypopharynx and Larynx Cancer: Are Longer Delays Associated with Higher Discrepancy between Clinical and Pathological Staging?下咽癌和喉癌诊断与治疗之间的时间间隔:较长的延迟是否与临床分期和病理分期之间的较高差异相关?
Int Arch Otorhinolaryngol. 2021 Jan;25(1):e108-e114. doi: 10.1055/s-0040-1708898. Epub 2020 May 4.
2
Assessment of cartilage invasion in case of laryngeal cancer by means of longitudinal sectioning for histopathology - Clinical implications.通过纵向切片进行组织病理学评估喉癌病例中的软骨侵犯 - 临床意义。
Rep Pract Oncol Radiother. 2019 Sep-Oct;24(5):443-449. doi: 10.1016/j.rpor.2019.07.002. Epub 2019 Jul 30.
3
Comparative Analysis of Clinical and Pathological Lymph Node Staging Data in Head and Neck Squamous Cell Carcinoma Patients Treated at the General Hospital Vienna.维也纳总医院治疗的头颈部鳞状细胞癌患者临床与病理淋巴结分期数据的对比分析
Radiol Oncol. 2018 May 11;52(2):173-180. doi: 10.2478/raon-2018-0020. eCollection 2018 Jun.
4
Predictors of clinical-pathologic stage discrepancy in oral cavity squamous cell carcinoma: A National Cancer Database study.口腔鳞状细胞癌临床病理分期差异的预测因素:一项国家癌症数据库研究。
Head Neck. 2018 Apr;40(4):828-836. doi: 10.1002/hed.25065. Epub 2018 Jan 23.
5
Clinicopathological parameters affecting nodal yields in patients with oral squamous cell carcinoma receiving selective neck dissection.影响接受选择性颈淋巴结清扫术的口腔鳞状细胞癌患者淋巴结检出数的临床病理参数。
J Craniomaxillofac Surg. 2017 Dec;45(12):2092-2096. doi: 10.1016/j.jcms.2017.08.020. Epub 2017 Sep 10.
6
Discrepancy between clinical and pathological neck staging in oral cavity carcinomas.口腔癌临床与病理颈部分期的差异。
Acta Otorrinolaringol Esp (Engl Ed). 2018 Mar-Apr;69(2):67-73. doi: 10.1016/j.otorri.2017.02.008. Epub 2017 May 12.
7
Discrepancy between cTNM and pTNM staging of oral cavity cancers and its prognostic significance.口腔癌cTNM与pTNM分期的差异及其预后意义。
J Surg Oncol. 2017 Jun;115(8):1011-1018. doi: 10.1002/jso.24606. Epub 2017 Mar 23.
8
Discordance between clinical and pathological TNM classification: influence on results of treatment and prognosis in patients with laryngeal cancer.临床与病理 TNM 分类的不相符:对喉癌患者治疗结果和预后的影响。
Neoplasma. 2017;64(2):305-310. doi: 10.4149/neo_2017_219.
9
Clinical and histopathological staging in oral squamous cell carcinoma - Comparison of the prognostic significance.口腔鳞状细胞癌的临床和组织病理学分期——预后意义比较
Oral Oncol. 2016 Sep;60:68-73. doi: 10.1016/j.oraloncology.2016.07.004. Epub 2016 Jul 11.
10
To evaluate disparity between clinical and pathological tumor-node-metastasis staging in oral cavity squamous cell carcinoma patients and its impact on overall survival: An institutional study.评估口腔鳞状细胞癌患者临床与病理肿瘤-淋巴结-转移分期之间的差异及其对总生存的影响:一项机构研究。
South Asian J Cancer. 2015 Oct-Dec;4(4):183-5. doi: 10.4103/2278-330X.175957.

颈部解剖术后头颈癌患者临床分期与病理分期的比较。

Comparison of Clinical and Pathological Staging in Patients with Head and Neck Cancer After Neck Dissection.

作者信息

Pinto João Viana, Sousa Mafalda Martins, Silveira Helena, Vales Fernando, Moura Carla Pinto

机构信息

Otorhinolaryngology Department, Centro Hospitalar Universitário de São João, EPE, Porto, Portugal.

Otorhinolaryngology, Surgery and Physiology Department, Faculdade de Medicina do Porto, Universidade do Porto, Porto, Portugal.

出版信息

Int Arch Otorhinolaryngol. 2023 Sep 14;27(4):e571-e578. doi: 10.1055/s-0042-1758208. eCollection 2023 Oct.

DOI:10.1055/s-0042-1758208
PMID:37876699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10593535/
Abstract

Clinical and pathological staging plays an important role on the prognosis of head and neck cancer (HNC) patients.  The present study aims to compare clinical and pathological T, N and overall staging in patients with HNC, to identify factors associated with these discrepancies, and to analyze and compare survival or disease-free survival in staging disagreements.  Retrospective cohort including every patient submitted to neck dissection from January 2010 to December 2020 in the department of Otorhinolaryngology of a tertiary hospital center.  A total of 79 patients were analyzed; their mean age was 58.52 ± 13.15 years old and 88.9% were male. Assessing overall staging, discrepancies were noted in 53% (36.4% upstaging and 16.6% downstaging) and were significantly associated with clinical overall staging (  = 0.006). Regarding T staging, differences were noted in 45.5% (30.3% upstaging and 15.2% downstaging) and were significantly associated with imaging modality (  = 0.016), clinical T staging (  = 0.049), and histology (  = 0.017). Discrepancies in N staging were noted in 38% (25.3% upstaging and 12.7% downstaging) and were significantly associated with age (  = 0.013), clinical N staging (  < 0.001), and presence of extranodal invasion (  < 0.001). Both in Overall, T, and N staging, the aforementioned disagreements were not associated with either higher mortality or higher disease relapse.  Overall, T, and N staging disagree in an important number of cases, and the overall stage can disagree in up to 53% of the cases. These disagreements do not seem to influence overall and disease-free survival.

摘要

临床和病理分期对头颈癌(HNC)患者的预后起着重要作用。本研究旨在比较HNC患者的临床和病理T、N分期及总体分期,确定与这些差异相关的因素,并分析和比较分期不一致时的生存率或无病生存率。回顾性队列研究纳入了2010年1月至2020年12月在一家三级医院中心耳鼻喉科接受颈部清扫术的每一位患者。共分析了79例患者;他们的平均年龄为58.52±13.15岁,88.9%为男性。评估总体分期时,发现53%存在差异(36.4%分期上调,16.6%分期下调),且与临床总体分期显著相关(P = 0.006)。关于T分期,45.5%存在差异(30.3%分期上调,15.2%分期下调),且与影像学检查方式(P = 0.016)、临床T分期(P = 0.049)和组织学(P = 0.017)显著相关。N分期差异为38%(25.3%分期上调,12.7%分期下调),且与年龄(P = 0.013)、临床N分期(P < 0.001)和结外侵犯的存在(P < 0.001)显著相关。在总体、T和N分期中,上述差异均与较高的死亡率或较高的疾病复发无关。总体而言,在相当数量的病例中,T和N分期以及总体分期存在差异,总体分期差异在高达53%的病例中出现。这些差异似乎并不影响总生存率和无病生存率。